These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18062165)

  • 1. [Changes of the thickness of the ciliary body after the latanoprost 0.005 % application].
    Výborný P; Hejsek L; Sicáková S; Pasta J
    Cesk Slov Oftalmol; 2007 Nov; 63(6):415, 418-21. PubMed ID: 18062165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 0.005% latanoprost on ocular anterior structures and ciliary body thickness.
    Marchini G; Ghilotti G; Bonadimani M; Babighian S
    J Glaucoma; 2003 Aug; 12(4):295-300. PubMed ID: 12897573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of latanoprost is independent of the width of the ciliary body face.
    Ritch R; Ishikawa H; Rothman R; Yu G; Liebmann JM
    J Glaucoma; 2002 Jun; 11(3):239-43. PubMed ID: 12140402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of latanoprost in patients with chronic angle-closure glaucoma and no visible ciliary-body face: a preliminary study.
    Kook MS; Cho HS; Yang SJ; Kim S; Chung J
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):75-84. PubMed ID: 15718831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
    Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
    Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial.
    Mansouri K; Orguel S; Mermoud A; Haefliger I; Flammer J; Ravinet E; Shaarawy T
    Br J Ophthalmol; 2008 Mar; 92(3):332-6. PubMed ID: 18211927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study.
    Dinslage S; Hueber A; Diestelhorst M; Krieglstein G
    Graefes Arch Clin Exp Ophthalmol; 2004 Aug; 242(8):654-60. PubMed ID: 15241610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of intraocular pressure reducing effects of three prostaglandin eyedrops in open-angle glaucoma].
    Huang HL; Sun XH; Xiao M
    Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):109-13. PubMed ID: 21426839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
    Hatanaka M; Reis A; Sano ME; Susanna R
    J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.
    Gandolfi SA; Cimino L
    Ophthalmology; 2003 Mar; 110(3):609-14. PubMed ID: 12623831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
    Facio AC; Reis AS; Vidal KS; de Moraes CG; Suzuki R; Hatanaka M; Susanna R
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):447-51. PubMed ID: 19860553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C; Oksüz H
    Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
    Walters TR; DuBiner HB; Carpenter SP; Khan B; VanDenburgh AM;
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of latanoprost additive therapy on uncontrolled glaucoma.
    Bayer A; Tas A; Sobaci G; Henderer JD
    Ophthalmologica; 2002; 216(6):443-8. PubMed ID: 12566890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
    Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K; Shirato S
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the combination of bimatoprost and latanoprost on intraocular pressure in primary open angle glaucoma: a randomised clinical trial.
    Doi LM; Melo LA; Prata JA
    Br J Ophthalmol; 2005 May; 89(5):547-9. PubMed ID: 15834081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.
    Choplin N; Bernstein P; Batoosingh AL; Whitcup SM;
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S19-25. PubMed ID: 15016558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.